T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Kura Oncology
KURA
$896M
| $366K | ﹤0.01% |
26,748
-11,048
| -29% | -$170K |
|
2277
TriMas Corp
TRS
$1.39B
| $365K | ﹤0.01% |
14,522
+2,662
| +22% | +$73.4K |
|
|
SPNE
2278
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $365K | ﹤0.01% |
64,181
+21,590
| +51% | +$137K |
|
|
CHCT
2279
Community Healthcare Trust
CHCT
$433M
| $364K | ﹤0.01% |
11,089
-1,045,969
| -99% | -$38.7M |
|
|
VSTO
2280
DELISTED
Vista Outdoor Inc.
VSTO
| $364K | ﹤0.01% |
14,942
+3,696
| +33% | +$105K |
|
|
SVC
2281
Service Properties Trust
SVC
$1.06B
| $363K | ﹤0.01% |
13,952
+2,184
| +19% | +$72.4K |
|
2282
Movado Group
MOV
$796M
| $362K | ﹤0.01% |
12,832
-1,987
| -13% | -$65.1K |
|
2283
Park Aerospace
PKE
$811M
| $362K | ﹤0.01% |
32,779
+7,806
| +31% | +$92.1K |
|
2284
Fulcrum Therapeutics
FULC
$283M
| $361K | ﹤0.01% |
44,605
+14,888
| +50% | +$107K |
|
2285
Joby Aviation
JOBY
$8.17B
| $361K | ﹤0.01% |
83,256
+21,992
| +36% | +$121K |
|
|
TRST
2286
Trustco Bank Corp NY
TRST
$971M
| $361K | ﹤0.01% |
11,459
-1,651
| -13% | -$54.8K |
|
2287
Viridian Therapeutics
VRDN
$2.49B
| $361K | ﹤0.01% |
+17,554
| New | +$316K |
|
2288
Hovnanian Enterprises
HOV
$799M
| $360K | ﹤0.01% |
10,064
+372
| +4% | +$16.5K |
|
2289
Washington Trust Bancorp
WASH
$767M
| $359K | ﹤0.01% |
7,703
+876
| +13% | +$44.8K |
|
|
ZEUS
2290
DELISTED
Olympic Steel
ZEUS
| $359K | ﹤0.01% |
15,698
+701
| +5% | +$18.9K |
|
2291
ADT
ADT
$5.46B
| $357K | ﹤0.01% |
47,637
+15,502
| +48% | +$117K |
|
2292
Artesian Resources
ARTNA
$369M
| $356K | ﹤0.01% |
7,397
-183,226
| -96% | -$9.74M |
|
2293
Banc of California
BANC
$3.11B
| $355K | ﹤0.01% |
22,192
+3,238
| +17% | +$56.4K |
|
|
INN
2294
Summit Hotel Properties
INN
$656M
| $354K | ﹤0.01% |
52,649
+6,181
| +13% | +$48.3K |
|
|
NVTA
2295
DELISTED
Invitae Corporation
NVTA
| $353K | ﹤0.01% |
143,241
-14,725
| -9% | -$44.7K |
|
2296
GoPro
GPRO
$117M
| $352K | ﹤0.01% |
71,221
+16,221
| +29% | +$96.4K |
|
2297
Heartland Express
HTLD
$979M
| $352K | ﹤0.01% |
24,581
+2,753
| +13% | +$41.4K |
|
|
PING
2298
DELISTED
Ping Identity Holding Corp.
PING
| $352K | ﹤0.01% |
+12,574
| New | +$312K |
|
|
SLCA
2299
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $351K | ﹤0.01% |
31,988
+4,452
| +16% | +$56.6K |
|
2300
Genesco
GCO
$394M
| $350K | ﹤0.01% |
8,881
-1,168
| -12% | -$62.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.